BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22646067)

  • 1. Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions.
    Garnock-Jones KP
    Paediatr Drugs; 2012 Aug; 14(4):263-9. PubMed ID: 22646067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycopyrrolate for chronic drooling in children.
    Eiland LS
    Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions.
    Zeller RS; Lee HM; Cavanaugh PF; Davidson J
    Ther Clin Risk Manag; 2012; 8():15-23. PubMed ID: 22298950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glycopyrrolate treatment for drooling in an adult with cerebral palsy].
    Neverlien PO; Sørumshagen L; Eriksen T; Grinna T; Kvalshaugen H; Lind AB
    Tidsskr Nor Laegeforen; 2001 Jan; 121(2):187-8. PubMed ID: 11475197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions.
    Zeller RS; Davidson J; Lee HM; Cavanaugh PF
    Ther Clin Risk Manag; 2012; 8():25-32. PubMed ID: 22298951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycopyrrolate treatment of chronic drooling.
    Blasco PA; Stansbury JC
    Arch Pediatr Adolesc Med; 1996 Sep; 150(9):932-5. PubMed ID: 8790123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycopyrronium for severe drooling in children.
    Drug Ther Bull; 2017 Aug; 55(8):93-96. PubMed ID: 28808084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: A randomized, double-blind, placebo-controlled trial.
    Fayoux P; Dinomais M; Shaw H; Villain F; Schwartz D; Rondeau S; Letellier G; Auvin S
    Dev Med Child Neurol; 2024 Jul; 66(7):910-918. PubMed ID: 38214675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compounded glycopyrrolate is a compelling choice for drooling children: five years of facility experience.
    Zanon D; Tumminelli C; Galimberti AMC; Torelli L; Maestro A; Barbi E; Maximova N
    Ital J Pediatr; 2021 Nov; 47(1):222. PubMed ID: 34742343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycopyrrolate for drooling in children with medical complexity under three years of age.
    Lovardi E; De Ioris MA; Lettori D; Geremia C; Staccioli S; Bella GD; Scrocca R; Scarselli A; Aversa M; De Peppo F; Campana A; Castelli E
    Ital J Pediatr; 2022 Jan; 48(1):2. PubMed ID: 34998418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In brief: Glycopyrrolate oral solution for sialorrhea.
    Med Lett Drugs Ther; 2011 Jan; 53(1355):4. PubMed ID: 21212745
    [No Abstract]   [Full Text] [Related]  

  • 12. The Effect of Glycopyrrolate on Nocturnal Sialorrhea in Patients Using Clozapine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial.
    Man WH; Colen-de Koning JC; Schulte PF; Cahn W; van Haelst IM; Doodeman HJ; Egberts TC; Heerdink ER; Wilting I
    J Clin Psychopharmacol; 2017 Apr; 37(2):155-161. PubMed ID: 28129312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy.
    Bachrach SJ; Walter RS; Trzcinski K
    Clin Pediatr (Phila); 1998 Aug; 37(8):485-90. PubMed ID: 9729704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycopyrrolate treatment of drooling in an adult male patient with cerebral palsy.
    Neverlien PO; Sorumshagen L; Eriksen T; Grinna T; Kvalshaugen H; Lind AB
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):320-2. PubMed ID: 10779132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebulized glycopyrrolate for drooling in a motor neuron patient.
    Strutt R; Fardell B; Chye R
    J Pain Symptom Manage; 2002 Jan; 23(1):2-3. PubMed ID: 11779659
    [No Abstract]   [Full Text] [Related]  

  • 16. The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.
    Parr JR; Weldon E; Pennington L; Steen N; Williams J; Fairhurst C; O'Hare A; Lodh R; Colver A
    Trials; 2014 Feb; 15():60. PubMed ID: 24533890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults.
    Blissit KT; Tillery E; Latham C; Pacheco-Perez J
    Am J Health Syst Pharm; 2014 Aug; 71(15):1282-7. PubMed ID: 25027535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study.
    Liang CS; Ho PS; Shen LJ; Lee WK; Yang FW; Chiang KT
    Schizophr Res; 2010 Jun; 119(1-3):138-44. PubMed ID: 20299191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral glycopyrrolate alleviates drooling in a patient with tongue cancer.
    Olsen AK; Sjøgren P
    J Pain Symptom Manage; 1999 Oct; 18(4):300-2. PubMed ID: 10534970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Nebulized Glycopyrrolate on Posterior Drooling in Patients with Brain Injury: Two Cases of Different Brain Lesions.
    Lee ZI; Yu KJ; Lee DH; Hong SK; Woo SB; Kim JM; Park D
    Am J Phys Med Rehabil; 2017 Aug; 96(8):e155-e158. PubMed ID: 28081026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.